Clinical Trial Update: Tacrolimus Formulation and Glucose Metabolism After Kidney Transplantation (TAGLUMET Trial) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating tacrolimus formulation and its effects on glucose metabolism in kidney transplant recipients with posttransplant diabetes me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation
• Posttransplant Diabetes Mellitus

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Posttransplant Diabetes Mellitus | Phase 4 | Status: COMPLETED